WallStSmart
IOVA

Iovance Biotherapeutics Inc

NASDAQ: IOVA · HEALTHCARE · BIOTECHNOLOGY

$3.36
+1.51% today

Updated 2026-04-30

Market cap
$1.41B
P/E ratio
P/S ratio
5.36x
EPS (TTM)
$-1.09
Dividend yield
52W range
$2 – $6
Volume
17.4M

Iovance Biotherapeutics Inc (IOVA) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-57303.00$-14448.00$-620805.00$-6.19M$-2.24M$-3.66M$-8.63M$-18.38M$-32.67M$-78.71M$-101.25M$-158.89M$-205.13M$-227.94M$-292.76M$-361.82M$-352.98M$-302.41M
Capital expenditures$0.00$0.00$0.00$31053.00$0.00$12705.00$1.59M$1.14M$1.52M$1.03M$1.20M$6.92M$46.79M$37.57M$20.43M$22.29M$11.07M$33.84M
Depreciation
Stock-based comp$19.68M$3.81M$8.52M$18.90M$11.97M$20.03M$24.28M$40.89M$69.77M$84.02M$62.63M$109.63M$61.58M
Free cash flow$-57303.00$-14448.00$-620805.00$-6.22M$-2.24M$-3.67M$-10.23M$-19.52M$-34.19M$-79.74M$-102.45M$-165.81M$-251.93M$-265.51M$-313.18M$-384.11M$-364.05M$-336.24M
Investing cash flow
Financing cash flow
Dividends paid$0.00$0.00$0.00$0.00$0.00$49.45M$0.00$1.00M
Share repurchases
Debt repayment
Net change in cash$-782252.00$-510217.00$19.67M$25.24M$-31.27M$73.13M$38.66M$-63.22M$-62.73M$53.44M$11.46M